By combining best-in-class sensitivity, crude sample robustness and a very fast transition capability, the Creoptix WAVE is revolutionizing the study of molecular interactions and changing the world of drug discovery.
By combining best-in-class sensitivity, crude sample robustness and a very fast transition capability, the Creoptix WAVE is revolutionizing the study of molecular interactions and changing the world of drug discovery.
Engineered around the proprietary waveguide interferometry technology and the powerful yet intuitive software, the WAVE offers superior data quality across the broadest range of compounds and sample types. The WAVE accurately characterizes weak binder kinetics with off-rates of 5/sec as well as high affinity antibodies with several hours of dissociation. The microfluidics sustains pure blood serum/plasma, cell supernatant, larger particles and even crude membrane preparations enabling novel approaches, especially in the field of membrane protein research.
